Binding Database

BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

12 articles for IJP de Esch

The following articles (labelled with PubMed ID or TBD) are for your review

PMID

Data

Article Title

Organization

Fragment-to-Lead Medicinal Chemistry Publications in 2022.

Astex Pharmaceuticals

Fragment-to-Lead Medicinal Chemistry Publications in 2021.

Astex Pharmaceuticals

Structural Analysis of Chemokine Receptor-Ligand Interactions.

Vrije Universiteit Amsterdam

Fragment-to-Lead Medicinal Chemistry Publications in 2020.

Vrije Universiteit Amsterdam

Fragment-to-Lead Medicinal Chemistry Publications in 2019.

Novartis Institutes For Biomedical Research

Fragment-to-Lead Medicinal Chemistry Publications in 2017.

Astex Pharmaceuticals

Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists.

Griffin Discoveries

Fragment-to-Lead Medicinal Chemistry Publications in 2018.

Frontier Medicines

4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H

Vrije Universiteit Amsterdam

Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2).

Vrije Universiteit Amsterdam

Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors.

Vrije Universiteit Amsterdam

Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity.

Vrije Universiteit Amsterdam